Morepen Laboratories Quarterly Results for Trading Insights
MOREPENLAB • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹41 Cr
QSept 2025
Morepen Laboratories Quarterly Results Key Highlights
- Revenue of ₹442 Cr in Sept 2025 (-6.2% vs Mar 2025, -0.2% vs Sept 2024)
- Net Profit of ₹41 Cr in Sept 2025 (+105.0% vs Mar 2025, +17.1% vs Sept 2024)
- EBITDA of ₹61 Cr in Sept 2025 (+29.8% vs Mar 2025)
- Operating Margin of 7.0% in Sept 2025 (-2.0pp vs Mar 2025)
- Earnings Per Share of ₹0.75 in Sept 2025 (+114.3% vs Mar 2025)
Morepen Laboratories Quarterly Results Analysis
| Metric | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | QoQ | YoY |
|---|---|---|---|---|---|---|---|
| Revenue (₹ Cr) | 442 | 471 | 430 | 488 | 443 | -6.2% | -0.2% |
| Net Profit (₹ Cr) | 41 | 20 | 11 | 28 | 35 | - | - |
| EBITDA (₹ Cr) | 61 | 47 | 29 | 50 | 49 | - | - |
| EPS (₹) | 0.75 | 0.35 | 0.20 | 0.50 | 0.65 | - | - |
| Operating Margin (%) | 7.0% | 9.0% | 6.0% | 10.0% | 10.0% | - | - |
Morepen Laboratories Share Price Trend Around Quarterly Results
Visualize Morepen Laboratories's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.
Related Pages for Morepen Laboratories
Additional stock information and data for MOREPENLAB
Revenue Trend (₹ Cr)
Dec 2025
488
Jun 2025
430
Mar 2025
471
Sept 2025
442
Net Profit Trend (₹ Cr)
Dec 2025
28
Jun 2025
11
Mar 2025
20
Sept 2025
41
Operating Margin Trend (%)
Dec 2025
10.0%
Jun 2025
6.0%
Mar 2025
9.0%
Sept 2025
7.0%
Sector Competitors - Quarterly Performance Comparison
Comparing Morepen Laboratories quarterly results with other companies in Healthcare sector
| Company Latest Quarter | Market Cap (₹ Cr) | Price (₹) | Revenue (₹ Cr) | Net Profit (₹ Cr) | Rev QoQ % | Rev YoY % | Profit Margin % | P/E Ratio |
|---|---|---|---|---|---|---|---|---|
|
Sun Pharmaceutical
Sept 2025 |
₹430,344.72 Cr | 1693.6 | 14,875 | 3,125 | +10.8% | - | 21.0% | 130.3 |
|
Divis Laboratories
Sept 2025 |
₹159,214.78 Cr | 5856.5 | 2,860 | 689 | +7.1% | - | 24.1% | 225.5 |
|
Torrent Pharmaceuti…
Sept 2025 |
₹144,367.29 Cr | 3987.2 | 3,219 | 591 | +11.3% | - | 18.4% | 227.3 |
|
Lupin
Sept 2025 |
₹107,238.09 Cr | 2274.5 | 6,921 | 1,485 | +23.2% | - | 21.5% | 70.3 |
|
Dr Reddys Laborator…
Sept 2025 |
₹106,974.57 Cr | 1217.3 | 9,135 | 1,337 | +1.1% | - | 14.6% | 75.2 |
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores
All amounts in ₹ Crores